Comment from Center for Science in the Public Interest

Summary: The Center for Science in the Public Interest (CSPI) opposes the CNPV pilot program, arguing that it prioritizes political goals over scientific evidence and risks patient safety through expedited review timelines. They express concerns regarding the lack of transparency in voucher selection and the potential for political appointees to exert undue influence on the drug approval process.